New York University's independent student newspaper, established in 1973.

Washington Square News

New York University's independent student newspaper, established in 1973.

Washington Square News

New York University's independent student newspaper, established in 1973.

Washington Square News

The new Merck COVID-19 treatment pill is currently awaiting FDA approval. Though the pill is effective at treating early-stage COVID patients, vaccines are still our best chance at ending the pandemic. (Staff Illustration by Manasa Gudavalli)

Opinion: The COVID-19 vaccines remain the best weapons against the pandemic

A new antiviral medication developed by Merck is awaiting FDA approval. The potential approval and widespread use of this new medication could help save thousands of lives, but the vaccine remains the best deterrent to the pandemic. 
Srishti Bungle, Deputy Opinion Editor October 19, 2021

On October 11th, the pharmaceutical company Merck requested that U.S. regulators approve their pill for use in treating COVID-19. Merck’s antiviral pill, named molnupiravir,...